Research & Discovery

The group's effort looked at the development steps required for successful implementation of MRM-MS assays as well as promising technical advances.

The firm is now clinically validating a mass spec-based test for quantifying native insulin and its therapeutic analogs and another test for type 2 diabetes. 

The findings demonstrate how one type of posttranscriptional modification gives RNA-binding proteins access to previously inaccessible regions of the mRNA.

The approach brings together the spatial resolution of optical microscope and the rich molecular information generated by imaging mass spectrometry.

The new tool is faster and generates more complete and accurate transcriptome assemblies than is possible with existing methods